Digital Health Global

APRIL 10, 2023

–(BUSINESS WIRE)– Aviceda Therapeutics , a clinical-stage biotech company focused on developing next-generation immuno-modulators to treat diseases such as cancer, today announced a strategic partnership with the Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast (Queen’s). CAMBRIDGE, Mass.–(BUSINESS

Life Science 88

Life Science BioTech Drug Development Health science 88

Society for Participatory Medicine

AUGUST 17, 2022

For a person like me, who is impacted by a rare, neurological, and incurable disease, it’s my mission to ensure that patients’ perspectives are represented early and throughout drug development. We plan to gather these stakeholders at the upcoming Huntington Study Group conference this November 3-5 in Tampa, FL, to develop next steps.

Drug Development 93

Drug Development BioTech 93

Healthcare IT Today

JANUARY 23, 2024

Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,

Drug Development 110

Drug Development Pharmaceuticals Life Science BioTech 110

Lloyd Price

DECEMBER 8, 2018

Existing investors include biotech giant Celgene Corp. , But key facets of its business didn’t develop as planned, say people familiar with the company. It had hoped to sell analytics to pharmaceutical companies as they increasingly incorporated genetic sequencing into drug development, these people say.

Pharmaceuticals 55

Pharmaceuticals Life Science BioTech Drug Development 55

Healthcare IT Today

APRIL 25, 2024

In our interview, Gil emphasizes the critical role of AI in expediting the discovery of new drugs, citing the lengthy and costly nature of traditional drug development processes. However, with AI-driven approaches, Aion Labs is paving the way for a paradigm shift in drug discovery.

Pharmaceuticals 131

Pharmaceuticals Drug Development BioTech Life Science 131

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Jane Rhodes, Ph.D.,

BioTech 88

BioTech Life Science Leadership Drug Development 88

Digital Health Global

NOVEMBER 30, 2023

Digital Health Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings. The use of DHTs in neurology trials produced consistent benefits on many levels.

Health Technology 157

Health Technology Digital Health Life Science BioTech 157

Digital Health Global

NOVEMBER 20, 2023

Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally. They can view historic data and forecast future trends.

Life Science 88

Life Science Digital Health Drug Development Patient Experience 88

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. QuantHealth proudly supports several large pharma companies, numerous biotechs, as well as CROs, and other industry partners.

BioTech 88

BioTech Drug Development Life Science Pharmaceuticals 88

Healthcare IT Today

MARCH 23, 2023

The additional funding will be used to build Protai’s oncology drug discovery pipeline, expand data acquisition as well as increase its discovery activities via pharma partnerships. These discoveries may be the key to significantly accelerating drug discovery and clinical development, lowering the time and costs of R&D.

Drug Development 96

Drug Development BioTech Health IT Healthcare IT 96

Healthcare IT Today

SEPTEMBER 28, 2022

Today, however, biotechnology companies like Invitae are meeting the patient at the time of genetic diagnosis (with their permission) and enrolling them in real-world natural history data collection. This same process is now being done at the individual and family basis through a distributed biotech model.

Drug Development 106

Drug Development BioTech Pain management Healthcare IT 106

Healthcare IT Today

NOVEMBER 7, 2023

This ML-driven adaptive process can significantly accelerate the clinical drug development process and increase certainty along the way, resulting in more efficient, targeted, and ultimately more successful clinical trials. Leveraging a wide range of parameters, this multifaceted approach is also valuable for drug repurposing efforts.

Drug Development 64

Drug Development BioTech Pharmaceuticals Health IT 64

Healthcare IT Today

JANUARY 9, 2023

Industry investments in data platforms to enable decentralized clinical trials and 3rd party data will improve healthcare outcomes: It’s no secret that having a diverse pool of individuals in clinical trials is critical to bringing life saving drugs to market. This data has historically been difficult to analyze en masse.

Health IT 103

Health IT Pharmaceuticals Drug Development Life Science 103